需体外膜氧合的重症急性肺栓塞患者的临床特征与短期结局:来自COMMAND VTE登记-2
本研究基于COMMAND VTE登记-2(医生发起、多中心、回顾性队列,连续纳入急性症状性静脉血栓栓塞症患者),分析其中需ECMO的急性症状性肺栓塞患者的临床特征、管理策略与结局。2035例急性症状性肺栓塞患者中76例(3.7%)需要ECMO。患者平均年龄58.4岁,男性34例(44.7%),诊断时心脏骤停或循环衰竭67例(88.2%)。30天全因死亡发生率为30.3%,均为肺栓塞相关死亡;30天大出血发生率为54.0%,绝大多数为操作部位相关出血和手术相关出血(22.4%)。30天全因死亡发生率在16例外科干预患者中为6.3%,16例导管干预患者中为43.8%,16例溶栓治疗患者中为25.0%,28例仅抗凝患者中为39.3%。作者认为当前日本大型真实世界静脉血栓栓塞症登记揭示了需ECMO的重症急性肺栓塞患者的临床特征与结局,提示未来临床试验存在若干未满足的需求。
要点
- 需ECMO的急性症状性肺栓塞占2035例中的76例(3.7%),诊断时心脏骤停或循环衰竭者67例(88.2%)。
- 30天全因死亡发生率为30.3%,且全部为肺栓塞相关死亡。
- 30天大出血发生率为54.0%,绝大多数为操作部位相关出血和手术相关出血(22.4%)。
- 30天全因死亡发生率:外科干预16例中6.3%,导管干预16例中43.8%,溶栓治疗16例中25.0%,仅抗凝28例中39.3%。
- 作者认为该真实世界登记提示未来临床试验存在若干未满足的需求。
适用人群与场景
- COMMAND VTE登记-2中连续纳入的急性症状性静脉血栓栓塞症患者,其中急性症状性肺栓塞2035例,需ECMO者76例(3.7%)。
- 需ECMO患者平均年龄58.4岁,男性34例(44.7%),诊断时心脏骤停或循环衰竭67例(88.2%)。
处置流程与药物剂量
- 76例需ECMO患者中,16例接受外科干预,16例接受导管干预,16例接受溶栓治疗,28例仅接受抗凝治疗。
研究设计与关键结果
- 研究类型:医生发起、多中心、回顾性队列研究(COMMAND VTE登记-2),连续纳入急性症状性静脉血栓栓塞症患者。
- 研究人群:2035例急性症状性肺栓塞患者中,76例(3.7%)需要ECMO。
- 主要终点:30天全因死亡发生率为30.3%,均为肺栓塞相关死亡。
- 关键次要终点:30天大出血发生率为54.0%,绝大多数为操作部位相关出血和手术相关出血(22.4%)。
- 亚组30天全因死亡发生率:外科干预16例中6.3%,导管干预16例中43.8%,溶栓治疗16例中25.0%,仅抗凝28例中39.3%。
证据类型、等级与局限
- 证据类型:多中心回顾性队列研究(COMMAND VTE登记-2)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为当前日本大型真实世界静脉血栓栓塞症登记揭示了需ECMO的重症急性肺栓塞患者的临床特征与结局,提示未来临床试验存在若干未满足的需求。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) might be required as a treatment option in patients with critical pulmonary embolism (PE). However, the clinical features and outcomes of the use of ECMO for critical acute PE are still limited. The present study aimed to clarify the clinical characteristics, management strategies and outcomes of patients with acute PE requiring ECMO in the current era using data from a large-scale observational database.
METHODS: We analyzed the data of the COMMAND VTE Registry-2: a physician-initiated, multicenter, retrospective cohort study enrolling consecutive patients with acute symptomatic venous thromboembolism (VTE). Among 2035 patients with acute symptomatic PE, there were 76 patients (3.7%) requiring ECMO.
RESULTS: Overall, the mean age was 58.4 years, and 34 patients (44.7%) were men. Cardiac arrest or circulatory collapse at diagnosis was reported in 67 patients (88.2%). The 30-day incidence of all-cause death was 30.3%, which were all PE-related deaths. The 30-day incidence of major bleeding was 54.0%, and the vast majority of bleedings were procedure site-related bleeding events and surgery-related bleeding (22.4%). The 30-day incidence of all-cause death was 6.3% in 16 patients with surgical intervention, 43.8% in 16 patients with catheter intervention, 25.0% in 16 patients with thrombolytic therapy, and 39.3% in 28 patients with anticoagulation only.
CONCLUSIONS: The current large real-world VTE registry in Japan revealed clinical features and outcomes of critical acute PE requiring ECMO in the current era, which suggested several unmet needs for future clinical trials.
参考来源
- Takabayashi K, Yamashita Y, Morimoto T, et al. Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2. J Intensive Care. 2024. PMID: 39497225. doi:10.1186/s40560-024-00755-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。